Atea Pharmaceuticals Inc
(AVIR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 121,190 | 4,058 | 32,252 | 30,713 | -10,947 |
| Depreciation Amortization | 29 | 22 | 15 | 7 | 19 |
| Accounts receivable | N/A | N/A | -50,000 | N/A | -5,815 |
| Accounts payable and accrued liabilities | 10,289 | 27,945 | 16,456 | 3,732 | -488 |
| Other Working Capital | -247,845 | -43,932 | -83,732 | -54,830 | 300,205 |
| Other Operating Activity | 29,332 | 325 | 50,824 | 3,541 | 13,760 |
| Operating Cash Flow | $-87,005 | $-11,582 | $-34,185 | $-16,837 | $296,734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | -26 |
| Investing Cash Flow | $-4 | $N/A | $N/A | $N/A | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,465 | 1,323 | 528 | 471 | 317,632 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 214,116 |
| Financing Cash Flow | $1,465 | $1,323 | $528 | $471 | $531,748 |
| Beginning Cash Position | 850,224 | 850,224 | 850,224 | 850,224 | 21,768 |
| End Cash Position | 764,680 | 839,965 | 816,567 | 833,858 | 850,224 |
| Net Cash Flow | $-85,544 | $-10,259 | $-33,657 | $-16,366 | $828,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,005 | -11,582 | -34,185 | -16,837 | 296,734 |
| Capital Expenditure | -4 | N/A | N/A | N/A | -26 |
| Free Cash Flow | -87,009 | -11,582 | -34,185 | -16,837 | 296,708 |